Cecilia Jones insider trades

Open-market stock purchases and sales by Cecilia Jones, Chief Financial Officer at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 11, 2021.

Recent trades

DateStockTradeValue
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Jun 18, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Apr 2, 2026AGIO Agios Pharmaceuticals, IncSold$109K
Apr 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$34.4K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$45.6K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$17.2K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncSold$48.7K
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 1, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Mar 1, 2026AGIO Agios Pharmaceuticals, IncBought (not open market)—
Dec 30, 2025AGIO Agios Pharmaceuticals, IncSold$79.4K
Dec 30, 2025AGIO Agios Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AGIO Agios Pharmaceuticals, Inc: 15 sales, last Jun 18, 2026
  • LOGC LogicBio Therapeutics, Inc: other filings, last Mar 1, 2022

Get free alerts when Cecilia Jones files a new trade →